Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1063 results for "aurobindo"

Buy Aurobindo Pharma; target of Rs 970: Axis Direct

Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 970 in its research report dated August 25, 2016. Money Control, 12 hours ago
[x]  

199 images for aurobindo

Business Standard India, 1 day ago
Livemint.com, 5 days ago
Business Today India, 6 days ago
Financial Express, 5 days ago
Business Standard India, 6 days ago
Financial Express, 6 days ago
Business Insider India, 1 day ago
Moneycontrol.com, 1 week ago
Sify, 1 day ago
Livemint.com, 1 day ago

Aurobindo's topline can swell by $350 m with Teva buy: PL

Indian pharmaceutical companies Aurobindo and Intas are among the final contenders for Teva’s generic drug business in UK. The strategy will help the companies expand their European business.
 Money Control1 day ago Aurobindo, Intas amid final contenders for buying out Teva UK  India Infoline1 day ago Aurobindo, Intas seek to boost Europe business with Teva bid  Business Standard1 day ago

Stocks to be on your radar: Tata Motors, Claris, Aurobindo

Some of the stocks that should be on your radar are: Tata Motors, Infosys, Aurobindo Pharma, Claris Lifesciences, GMR Infrastructure, Future Retail.
 Money Control1 day ago Stocks in news: LT, Bharti, Tata Steel, Claris, Dishman, Zydus  Money Control1 month ago

Stocks in news: Aurobindo, Future Retail, Centrum, GMR, Claris

Tata Motors | Coal India | Cairn India | ONGC | IOC | DLF | GMR Infrastructure | Ricoh India | JSW Steel | Neuland Laboratories | Claris Life | Electrosteel Castings | Pratibha Industries | JBF Industries and Alankit are stocks, which are in the news today.
 Money Control1 day ago Stocks in news: Tata Motors, DLF, Guj Gas, Indian Hotels, Ricoh  Money Control1 month ago
Sify

Aurobindo Pharma eyes Teva's UK & Irish portfolios

Aurobindo Pharma is very much in the race to acquire the UK and Irish portfolio of Teva, the Israeli generics giant. Both Aurobindo Pharma and Intas, the other contender, have bid for the stake, offering around $1 billion along with firm financing ...
 Sify1 day ago Aurobindo eyes Teva generics in U.K., Iceland, Ireland  FiercePharma1 month ago Aurobindo in fray for $1.5b Teva portfolio  The Financial Chronicle1 month ago

Buy LT, Aurobindo Pharma, HCL Technologies: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com recommends buying Larsen and Toubro, Aurobindo Pharma and HCL Technologies.
 Money Control5 days ago By BPCL, Aurobindo Pharma; sell Mindtree: Sudarshan Sukhani  Money Control1 week ago Short Pidilite, Aurobindo Pharma: Sudarshan Sukhani  Money Control2 weeks ago

Nifty ends above 8650 ahead of Aug FO expiry; Aurobindo up 7%

The BSE Midcap and Smallcap indices rose 0.6 percent each on positive market breadth. About 1538 shares advanced against 1176 declining shares on the exchange.
 Money Control6 days ago Sensex hovers around 28000; NTPC, Cipla, Aurobindo shares surge  Money Control6 days ago Nifty hovers around 8100; UltraTech, Aurobindo, BPCL, BoB rally  Money Control2 months ago
Money Today

Stocks in focus: Aurobindo, Welspun, Idea Cellular

Shares of Aurobindo Pharma today surged nearly 6 per cent after the company reported 23.81 per cent rise in consolidated net profit for the first quarter ended June 30. The scrip gained 5.59 per cent to Rs 777.50 on the BSE. On the NSE, shares of the company ...
 Business Line6 days ago Aurobindo Pharma shares surge 6% post Q1, top Nifty gainer  Money Today6 days ago Aurobindo Pharma shares jump nearly 6% post Q1 earnings  Business Standard6 days ago

Aurobindo Pharma gains on strong Q1 results

The stock rallied 6% to Rs 778 after the company reported 24% YoY jump in consolidated net profit at Rs 585 crore in Q1FY17.
 Business Standard6 days ago Aurobindo Pharma Q1 Net up 24 pc at Rs 585 cr  Business Standard6 days ago Aurobindo Pharma Q1 net up 24%  India Infoline6 days ago Aurobindo Pharma Q1 net profit up 24% at Rs 584 crore  Business Standard6 days ago
The Telegraph

Aurobindo gets taste of tough poser pill

Ace investor Rakesh Jhunjhunwala today grilled the top management of Aurobindo Pharma on revenue potential, fund-raising and capital expenditure in a conference call. According to stock exchange data, Jhunjhunwala holds more than 65 lakh shares of Aurobindo ...
 The Telegraph5 days ago Aurobindo Pharma ends marginally higher; gets FDA nod for Linezolid Injection  India Infoline3 weeks ago Aurobindo Pharma Gets US Regulator's Nod For Anti-Infective Injection  NDTV3 weeks ago Aurobindo Pharma receives US FDA nod for anti-infective drug  Business Standard3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - aurobindo
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less